XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.630
-0.420 (-20.49%)
At close: Oct 9, 2025, 4:00 PM EDT
1.760
+0.130 (7.98%)
After-hours: Oct 9, 2025, 4:07 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $15.11 million as of October 9, 2025. Its market cap has decreased by -54.39% in one year.
Market Cap
15.11M
Enterprise Value
13.99M
1-Year Change
-54.39%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $15.11M, a decrease of -91.60%. That is a compound annual growth rate of -11.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 23.43M | 4.66% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | 15.68M | 124.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |